Cargando…

Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities

BACKGROUND: Canadian long‐term care facility (LTCF) residents experienced higher death rates compared to other countries during the first wave of the COVID‐19 pandemic. This cohort study analyzes the individual, therapeutic, and institutional factors associated with death in LTCFs. METHODS: Institut...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi Sophie, Charland, Katia, Quach, Caroline, Nguyen, Quoc Dinh, Zinszer, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353371/
https://www.ncbi.nlm.nih.gov/pubmed/35906882
http://dx.doi.org/10.1111/jgs.17975
_version_ 1784762854281314304
author Zhang, Xi Sophie
Charland, Katia
Quach, Caroline
Nguyen, Quoc Dinh
Zinszer, Kate
author_facet Zhang, Xi Sophie
Charland, Katia
Quach, Caroline
Nguyen, Quoc Dinh
Zinszer, Kate
author_sort Zhang, Xi Sophie
collection PubMed
description BACKGROUND: Canadian long‐term care facility (LTCF) residents experienced higher death rates compared to other countries during the first wave of the COVID‐19 pandemic. This cohort study analyzes the individual, therapeutic, and institutional factors associated with death in LTCFs. METHODS: Institutional data for 17 LTCFs in Montreal, Canada were obtained from local administrative registries. Individual data for 1197 residents infected by SARS‐CoV‐2 between February 23 and July 11, 2020 were obtained through chart reviews. A multivariable modified Poisson regression model, which accounted for LTCF clustering, was used to identify resident and facility covariates associated with 30‐day mortality after COVID‐19 diagnosis. RESULTS: Severe shortage of licensed practical nurses (RR 2.60 95% CI 1.20–5.61) and medium‐sized facilities compared to smaller‐sized facilities (RR 2.73 95% CI 1.23–6.07) were associated with 30‐day mortality. Later COVID‐19 diagnosis (RR 0.98 95% CI 0.97–0.99 per additional day) was associated with survival. Individual risk factors for death included age (RR 1.33 95% CI 1.23–1.45 per additional 10 years), male sex (RR 1.46 95% CI 1.24–1.71), functional impairment (RR 1.08 95% CI 1.04–1.12 per unit increase of SMAF), as well as a diagnosis of congestive heart failure (RR 1.31 95% CI 1.04–1.66) and neurocognitive disorder (RR 1.31 95% CI 1.01–1.70). Among severe cases, anticoagulation was associated with survival (RR 0.70 95% CI 0.51–0.96). CONCLUSIONS: This study identified practical nurse shortages and facility size as institutional risk factors for COVID‐19 death. Anticoagulation was associated with survival among severe cases.
format Online
Article
Text
id pubmed-9353371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93533712022-08-05 Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities Zhang, Xi Sophie Charland, Katia Quach, Caroline Nguyen, Quoc Dinh Zinszer, Kate J Am Geriatr Soc Clinical Investigations BACKGROUND: Canadian long‐term care facility (LTCF) residents experienced higher death rates compared to other countries during the first wave of the COVID‐19 pandemic. This cohort study analyzes the individual, therapeutic, and institutional factors associated with death in LTCFs. METHODS: Institutional data for 17 LTCFs in Montreal, Canada were obtained from local administrative registries. Individual data for 1197 residents infected by SARS‐CoV‐2 between February 23 and July 11, 2020 were obtained through chart reviews. A multivariable modified Poisson regression model, which accounted for LTCF clustering, was used to identify resident and facility covariates associated with 30‐day mortality after COVID‐19 diagnosis. RESULTS: Severe shortage of licensed practical nurses (RR 2.60 95% CI 1.20–5.61) and medium‐sized facilities compared to smaller‐sized facilities (RR 2.73 95% CI 1.23–6.07) were associated with 30‐day mortality. Later COVID‐19 diagnosis (RR 0.98 95% CI 0.97–0.99 per additional day) was associated with survival. Individual risk factors for death included age (RR 1.33 95% CI 1.23–1.45 per additional 10 years), male sex (RR 1.46 95% CI 1.24–1.71), functional impairment (RR 1.08 95% CI 1.04–1.12 per unit increase of SMAF), as well as a diagnosis of congestive heart failure (RR 1.31 95% CI 1.04–1.66) and neurocognitive disorder (RR 1.31 95% CI 1.01–1.70). Among severe cases, anticoagulation was associated with survival (RR 0.70 95% CI 0.51–0.96). CONCLUSIONS: This study identified practical nurse shortages and facility size as institutional risk factors for COVID‐19 death. Anticoagulation was associated with survival among severe cases. John Wiley & Sons, Inc. 2022-07-30 /pmc/articles/PMC9353371/ /pubmed/35906882 http://dx.doi.org/10.1111/jgs.17975 Text en © 2022 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Investigations
Zhang, Xi Sophie
Charland, Katia
Quach, Caroline
Nguyen, Quoc Dinh
Zinszer, Kate
Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title_full Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title_fullStr Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title_full_unstemmed Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title_short Institutional, therapeutic, and individual factors associated with 30‐day mortality after COVID‐19 diagnosis in Canadian long‐term care facilities
title_sort institutional, therapeutic, and individual factors associated with 30‐day mortality after covid‐19 diagnosis in canadian long‐term care facilities
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353371/
https://www.ncbi.nlm.nih.gov/pubmed/35906882
http://dx.doi.org/10.1111/jgs.17975
work_keys_str_mv AT zhangxisophie institutionaltherapeuticandindividualfactorsassociatedwith30daymortalityaftercovid19diagnosisincanadianlongtermcarefacilities
AT charlandkatia institutionaltherapeuticandindividualfactorsassociatedwith30daymortalityaftercovid19diagnosisincanadianlongtermcarefacilities
AT quachcaroline institutionaltherapeuticandindividualfactorsassociatedwith30daymortalityaftercovid19diagnosisincanadianlongtermcarefacilities
AT nguyenquocdinh institutionaltherapeuticandindividualfactorsassociatedwith30daymortalityaftercovid19diagnosisincanadianlongtermcarefacilities
AT zinszerkate institutionaltherapeuticandindividualfactorsassociatedwith30daymortalityaftercovid19diagnosisincanadianlongtermcarefacilities